<DOC>
	<DOCNO>NCT02267226</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Octafibrin on-demand treatment acute bleed subject congenital fibrinogen deficiency .</brief_summary>
	<brief_title>Efficacy Safety Study Octafibrin On-demand Treatment Acute Bleeding Prevent Bleeding During After Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Afibrinogenemia</mesh_term>
	<criteria>Aged ≥12 year Documented diagnosis congenital fibrinogen deficiency , expect require ondemand treatment bleed surgical prophylaxis : Fibrinogen deficiency manifest afibrinogenaemia severe hypofibrinogenaemia . Historical plasma fibrinogen activity &lt; 50 mg/dL level limit detection local assay method . Having acute bleeding episode ( spontaneous trauma ) planning undergo elective surgery . Informed consent sign subject legal guardian . Life expectancy &lt; 6 month . Bleeding disorder congenital fibrinogen deficiency , include dysfibrinogenaemia . Prophylactic treatment fibrinogen concentrate . Treatment : Any fibrinogen concentrate fibrinogencontaining blood product within 2 week prior start treatment bleeding episode surgery . Any coagulationactive drug ( i.e. , nonsteroidal antiinflammatory drug , warfarin , coumarin derivative , platelet aggregation inhibitor ) within 1 week prior start treatment bleed episode surgery , plan expect medication time period Day 1 24 hour ( i.e. , 1 day ) last Octafibrin infusion . Presence history : Hypersensitivity study medication . Deep vein thrombosis pulmonary embolism within 1 year prior start treatment bleed episode surgery . Arterial thrombosis within 1 year prior start treatment bleed episode surgery Hypersensitivity human plasma protein . Oesophageal varicose bleeding . Endstage liver disease ( i.e. , ChildPugh score B C ) . Pregnant woman within first 20 week gestation . Currently breastfeed . Known positive HIV infection viral load &gt; 200 particles/μL &gt; 400,000 copies/mL . Polytrauma 1 year prior start treatment bleed episode surgery . Diagnosis suspicion neutralize antifibrinogen inhibitor currently time past . Acute chronic medical condition may , opinion investigator , affect conduct study , include Subjects receive immunemodulating drug ( antiretroviral chemotherapy ) alphainterferon , prednisone ( equivalent &gt; 10 mg/day ) , similar drug study start . Subjects evidence history ( within previous 12 month ) abuse licit illicit drug substance . Participation another interventional clinical study currently past 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>